Zhang, Ke
Wang, Qifeng
Cao, Jianzhong
Fan, Chengcheng
Shen, Wenbin
Xiao, Qin
Ge, Xiaolin
Zhang, Tian
Liu, Xiao
Chen, Xi
Dong, Jie
Li, Zewei
Zheng, Zhunhao
Yan, Cihui
Wang, Ping
Pang, Qingsong
Zhang, Wencheng
Funding for this research was provided by:
National Natural Science Foundation of China (82273083, 82272733)
Article History
Received: 20 February 2024
Accepted: 17 February 2025
First Online: 25 February 2025
Declarations
:
: Institutional review board approval was obtained from the ethics committee of Tianjin Cancer Hospital (E20230954) in August 2023. This trial was published under NCT06061146 on ClinicalTrials.gov. All the participants signed an informed consent form.
: Not applicable.
: The authors declare no competing interests.